BioVie Inc (BIVI)

Name: BioVie Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$0.0

Net Income

-$6.1M

Operating Margin

N/A

Free Cash Flow

-$19.0M

Debt / Assets

11.8%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for BioVie Inc (BIVI).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-03-31	2024-12-31
Revenue	0	0	0	0
Cost of Revenue	57,344	57,344	57,344	57,344
Gross Profit	-57,344	-57,344	-57,344	-57,344
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,935,482	2,290,881	1,586,000	2,531,000
Operating Expenses	6,204,961	5,227,251	2,931,000	7,235,000
Operating Income	-6,262,305	-5,284,595	-2,988,000	-7,293,000
Interest Expense	5,967	1,989	4,998	66,700
Income Before Tax	-6,069,475	-5,131,101	-2,788,000	-7,157,000
Income Tax Expense	0	0	0	-7,157,000
Net Income	-6,069,475	-5,131,101	-2,788,000	-7,157,000
Per Share
EPS	-0.77	-0.98	-0.15	-0.46
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for BioVie Inc (BIVI).
Income Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Revenue	0	0	0	0	0
Cost of Revenue	229,377	0	266,842	237,421	0
Gross Profit	-229,377	0	-267,000	-237,421	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	8,570,089	0	11,552,000	9,765,259	0
Operating Expenses	17,836,823	32,179,585	45,080,000	27,252,977	138,054,139
Operating Income	-18,066,200	-32,179,585	-45,080,000	-27,252,977	-138,054,139
Interest Expense	332,720	2,893,922	4,300,000	2,162,989	559,455
Income Before Tax	-17,542,120	-32,120,533	-50,256,000	-26,084,468	-130,249,204
Income Tax Expense	0	0	4,300,000	-3,287,418	0
Net Income	-17,542,120	-32,120,533	-50,256,000	-22,797,050	-130,249,204
Per Share
EPS	-12.12	-73.05	-7.73	-0.92	-10.50
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for BioVie Inc (BIVI).
Balance Sheet (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Assets
Cash and Cash Equivalents	17,544,547	23,843,798	19,460,883	18,641,716
Short Term Investments	0	0	14,477,726	0
Net Receivables	2,104,050	0	0	0
Inventory	0	0	0	0
Total Current Assets	20,698,494	24,048,190	34,041,135	18,779,595
Property Plant Equipment	339,653	406,726	80,789	118,254
Goodwill and Intangibles	524,052	753,429	982,806	1,212,183
Total Assets	21,562,199	25,208,345	35,104,730	20,114,594
Liabilities
Account Payables	2,200,320	3,586,912	3,476	2,443
Short Term Debt	74,464	5,761,553	9,149,983	38,884
Total Current Liabilities	2,274,784	9,352,236	14,494,669	4,169,174
Long Term Debt	275,430	349,894	5,269,775	12,226,100
Total Liabilities	2,550,214	9,702,130	19,764,444	16,443,659
Shareholders Equity
Retained Earnings	-352,144,000	-334,232,661	-301,225,705	-250,969,890
Total Shareholders Equity	19,011,985	15,506,215	15,340,286	3,670,935

Balance sheet annual history for BioVie Inc (BIVI).
Balance Sheet (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Assets
Cash and Cash Equivalents	17,544,547	23,843,798	19,460,883	18,641,716	4,511,642
Short Term Investments	0	0	14,477,726	0	0
Net Receivables	2,104,050	0	0	0	0
Inventory	0	0	0	0	0
Total Current Assets	20,698,494	24,048,190	34,041,135	18,779,595	4,605,129
Property Plant Equipment	339,653	406,726	80,789	118,254	0
Goodwill and Intangibles	524,052	753,429	982,806	1,212,183	1,441,560
Total Assets	21,562,199	25,208,345	35,104,730	20,114,594	6,046,689
Liabilities
Account Payables	2,200,320	3,586,912	3,476	2,443	0
Short Term Debt	74,464	5,761,553	9,149,983	38,884	0
Total Current Liabilities	2,274,784	9,352,236	14,494,669	4,169,174	996,374
Long Term Debt	275,430	349,894	5,269,775	12,226,100	0
Total Liabilities	2,550,214	9,702,130	19,764,444	16,443,659	996,374
Shareholders Equity
Retained Earnings	-352,144,000	-334,232,661	-301,225,705	-250,969,890	-224,885,422
Total Shareholders Equity	19,011,985	15,506,215	15,340,286	3,670,935	5,050,315

Cash flow quarterly history for BioVie Inc (BIVI).
Cash Flow Statement (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Operating Activities
Net Income	-17,542,120	-32,120,533	-50,255,815	-26,084,468
Depreciation & Amortization	229,377	229,377	229,377	229,377
Stock Based Compensation	2,471,936	4,660,114	6,375,392	6,194,079
Change in Working Capital	-4,396,490	-86,843	-270,439	2,750,786
Operating Cash Flow	-19,025,205	-27,945,024	-40,252,881	-18,990,850
Investing Activities
Capital Expenditure	0	0	0	0
Investments	0	0	0	0
Investing Cash Flow	0	14,525,000	-14,301,135	0
Financing Activities
Debt Repayment	-5,850,000	0	0	-14,609,900
Common Stock Issued/Repurchased	15,674,613	27,802,939	55,370,943	18,511,009
Dividends Paid	0	0	0	0
Financing Cash Flow	12,725,954	17,802,939	55,373,183	33,120,924
Summary
Free Cash Flow	-19,025,205	-27,945,024	-40,252,881	-18,990,850
Net Change in Cash	-6,299,251	4,382,915	819,167	14,130,074

Cash flow annual history for BioVie Inc (BIVI).
Cash Flow Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Operating Activities
Net Income	-17,542,120	-32,120,533	-50,255,815	-26,084,468	-130,249,204
Depreciation & Amortization	229,377	229,377	229,377	229,377	229,377
Stock Based Compensation	2,471,936	4,660,114	6,375,392	6,194,079	3,019,809
Change in Working Capital	-4,396,490	-86,843	-270,439	2,750,786	19,466
Operating Cash Flow	-19,025,205	-27,945,024	-40,252,881	-18,990,850	-10,453,047
Investing Activities
Capital Expenditure	0	0	0	0	0
Investments	0	0	0	0	0
Investing Cash Flow	0	14,525,000	-14,301,135	0	0
Financing Activities
Debt Repayment	-5,850,000	0	0	-14,609,900	-1,821,818
Common Stock Issued/Repurchased	15,674,613	27,802,939	55,370,943	18,511,009	15,628,010
Dividends Paid	0	0	0	0	0
Financing Cash Flow	12,725,954	17,802,939	55,373,183	33,120,924	14,927,494
Summary
Free Cash Flow	-19,025,205	-27,945,024	-40,252,881	-18,990,850	-10,453,047
Net Change in Cash	-6,299,251	4,382,915	819,167	14,130,074	4,474,447